130 related articles for article (PubMed ID: 20616615)
1. Cystic fibrosis transmembrane conductance regulator can export hyaluronan.
Schulz T; Schumacher U; Prante C; Sextro W; Prehm P
Pathobiology; 2010; 77(4):200-9. PubMed ID: 20616615
[TBL] [Abstract][Full Text] [Related]
2. Recovery of ΔF508-CFTR function by analogs of hyaluronan disaccharide.
Nowakowska E; Schulz T; Molenda N; Schillers H; Prehm P
J Cell Biochem; 2012 Jan; 113(1):156-64. PubMed ID: 21882224
[TBL] [Abstract][Full Text] [Related]
3. Cystic fibrosis transmembrane conductance regulator (CFTR) nucleotide-binding domain 1 (NBD-1) and CFTR truncated within NBD-1 target to the epithelial plasma membrane and increase anion permeability.
Clancy JP; Hong JS; Bebök Z; King SA; Demolombe S; Bedwell DM; Sorscher EJ
Biochemistry; 1998 Oct; 37(43):15222-30. PubMed ID: 9790686
[TBL] [Abstract][Full Text] [Related]
4. A delta F508 mutation in mouse cystic fibrosis transmembrane conductance regulator results in a temperature-sensitive processing defect in vivo.
French PJ; van Doorninck JH; Peters RH; Verbeek E; Ameen NA; Marino CR; de Jonge HR; Bijman J; Scholte BJ
J Clin Invest; 1996 Sep; 98(6):1304-12. PubMed ID: 8823295
[TBL] [Abstract][Full Text] [Related]
5. Expression of delta F508 cystic fibrosis transmembrane conductance regulator protein and related chloride transport properties in the gallbladder epithelium from cystic fibrosis patients.
Dray-Charier N; Paul A; Scoazec JY; Veissière D; Mergey M; Capeau J; Soubrane O; Housset C
Hepatology; 1999 Jun; 29(6):1624-34. PubMed ID: 10347100
[TBL] [Abstract][Full Text] [Related]
6. Partial correction of endogenous DeltaF508 CFTR in human cystic fibrosis airway epithelia by spliceosome-mediated RNA trans-splicing.
Liu X; Jiang Q; Mansfield SG; Puttaraju M; Zhang Y; Zhou W; Cohn JA; Garcia-Blanco MA; Mitchell LG; Engelhardt JF
Nat Biotechnol; 2002 Jan; 20(1):47-52. PubMed ID: 11753361
[TBL] [Abstract][Full Text] [Related]
7. Turnover of the cystic fibrosis transmembrane conductance regulator (CFTR): slow degradation of wild-type and delta F508 CFTR in surface membrane preparations of immortalized airway epithelial cells.
Wei X; Eisman R; Xu J; Harsch AD; Mulberg AE; Bevins CL; Glick MC; Scanlin TF
J Cell Physiol; 1996 Aug; 168(2):373-84. PubMed ID: 8707873
[TBL] [Abstract][Full Text] [Related]
8. Surface expression of the cystic fibrosis transmembrane conductance regulator mutant DeltaF508 is markedly upregulated by combination treatment with sodium butyrate and low temperature.
Heda GD; Marino CR
Biochem Biophys Res Commun; 2000 May; 271(3):659-64. PubMed ID: 10814518
[TBL] [Abstract][Full Text] [Related]
9. Dynasore inhibits removal of wild-type and DeltaF508 cystic fibrosis transmembrane conductance regulator (CFTR) from the plasma membrane.
Young A; Gentzsch M; Abban CY; Jia Y; Meneses PI; Bridges RJ; Bradbury NA
Biochem J; 2009 Jul; 421(3):377-85. PubMed ID: 19442237
[TBL] [Abstract][Full Text] [Related]
10. Specific rescue of cystic fibrosis transmembrane conductance regulator processing mutants using pharmacological chaperones.
Wang Y; Bartlett MC; Loo TW; Clarke DM
Mol Pharmacol; 2006 Jul; 70(1):297-302. PubMed ID: 16624886
[TBL] [Abstract][Full Text] [Related]
11. Extensive posttranscriptional deletion of the coding sequences for part of nucleotide-binding fold 1 in respiratory epithelial mRNA transcripts of the cystic fibrosis transmembrane conductance regulator gene is not associated with the clinical manifestations of cystic fibrosis.
Chu CS; Trapnell BC; Curristin SM; Cutting GR; Crystal RG
J Clin Invest; 1992 Sep; 90(3):785-90. PubMed ID: 1381723
[TBL] [Abstract][Full Text] [Related]
12. Sildenafil (Viagra) corrects DeltaF508-CFTR location in nasal epithelial cells from patients with cystic fibrosis.
Dormer RL; Harris CM; Clark Z; Pereira MM; Doull IJ; Norez C; Becq F; McPherson MA
Thorax; 2005 Jan; 60(1):55-9. PubMed ID: 15618584
[TBL] [Abstract][Full Text] [Related]
13. Purinergic signaling underlies CFTR control of human airway epithelial cell volume.
Braunstein GM; Zsembery A; Tucker TA; Schwiebert EM
J Cyst Fibros; 2004 Jun; 3(2):99-117. PubMed ID: 15463893
[TBL] [Abstract][Full Text] [Related]
14. S-nitrosoglutathione increases cystic fibrosis transmembrane regulator maturation.
Zaman K; McPherson M; Vaughan J; Hunt J; Mendes F; Gaston B; Palmer LA
Biochem Biophys Res Commun; 2001 Jun; 284(1):65-70. PubMed ID: 11374871
[TBL] [Abstract][Full Text] [Related]
15. Rescue of DeltaF508-CFTR (cystic fibrosis transmembrane conductance regulator) by curcumin: involvement of the keratin 18 network.
Lipecka J; Norez C; Bensalem N; Baudouin-Legros M; Planelles G; Becq F; Edelman A; Davezac N
J Pharmacol Exp Ther; 2006 May; 317(2):500-5. PubMed ID: 16424149
[TBL] [Abstract][Full Text] [Related]
16. Knockout mouse models for intestinal electrolyte transporters and regulatory PDZ adaptors: new insights into cystic fibrosis, secretory diarrhoea and fructose-induced hypertension.
Seidler U; Singh A; Chen M; Cinar A; Bachmann O; Zheng W; Wang J; Yeruva S; Riederer B
Exp Physiol; 2009 Feb; 94(2):175-9. PubMed ID: 18931049
[TBL] [Abstract][Full Text] [Related]
17. Functional expression of cystic fibrosis transmembrane conductance regulator in mouse chondrocytes.
Liang H; Yang L; Ma T; Zhao Y
Clin Exp Pharmacol Physiol; 2010 Apr; 37(4):506-8. PubMed ID: 19843093
[TBL] [Abstract][Full Text] [Related]
18. Defective formation of PKA/CnA-dependent annexin 2-S100A10/CFTR complex in DeltaF508 cystic fibrosis cells.
Borthwick LA; Riemen C; Goddard C; Colledge WH; Mehta A; Gerke V; Muimo R
Cell Signal; 2008 Jun; 20(6):1073-83. PubMed ID: 18346874
[TBL] [Abstract][Full Text] [Related]
19. NDPK-A (but not NDPK-B) and AMPK alpha1 (but not AMPK alpha2) bind the cystic fibrosis transmembrane conductance regulator in epithelial cell membranes.
Crawford RM; Treharne KJ; Best OG; Riemen CE; Muimo R; Gruenert DC; Arnaud-Dabernat S; Daniel JY; Mehta A
Cell Signal; 2006 Oct; 18(10):1595-603. PubMed ID: 16466905
[TBL] [Abstract][Full Text] [Related]
20. Expression of cystic fibrosis transmembrane conductance regulator in human gallbladder epithelial cells.
Dray-Charier N; Paul A; Veissiere D; Mergey M; Scoazec JY; Capeau J; Brahimi-Horn C; Housset C
Lab Invest; 1995 Dec; 73(6):828-36. PubMed ID: 8558844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
